Acknowledging the improved outcomes achieved with ART [14], WHO guidelines have moved beyond 2006 recommendations guided by CD4 count [10] to now recommend ART in all people with TB-HIV co-infection [13]. The gene discussed is CD4; the disease is tuberculosis.